Literature DB >> 1388269

A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses.

M Clerici1, E Roilides, C S Via, P A Pizzo, G M Shearer.   

Abstract

Defective in vitro T helper cell (Th) function can occur in asymptomatic human immunodeficiency virus (HIV)-seropositive (HIV+) individuals. A characteristic, early finding is the loss of an in vitro response to recall antigens, such as influenza A virus (FLU), despite an intact Th response to alloantigen (ALLO). To determine whether suppressor cells and/or inhibitory factors could contribute to this HIV-associated Th immunodeficiency, coculture studies were performed using peripheral blood leukocytes (PBLs) from monozygotic twins, one of whom was HIV-infected (HIV+) and one of whom was uninfected (HIV-seronegative, HIV-). In vitro Th function was measured as interleukin 2 production or proliferation to FLU and ALLO. Two pairs of twins were repetitively studied. A single HIV+ individual with multiple samples of cryopreserved PBLs over 6 years (including a HIV- specimen) was also studied. PBLs from the HIV+, but not from the HIV-, individuals demonstrated defective in vitro Th function in response to FLU but not to ALLO. PBLs from HIV+ individuals could induce a similar defect in the Th function of syngeneic or autologous HIV- PBLs. This suppression was generated by CD4-depleted, but not by CD8-depleted, PBLs. A suppressive factor from CD8+ cells of HIV+ donors was generated by 24-hr unstimulated cultures of HIV+ PBLs. This factor inhibited FLU but not ALLO responses of autologous, syngeneic, or allogeneic HIV- PBLs. This suppressive effect could not be explained by HIV infection or replication during the culture period. These results demonstrate that selective abrogation of Th function to recall antigens in HIV+ individuals is associated with an inhibitory factor produced by CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388269      PMCID: PMC49932          DOI: 10.1073/pnas.89.18.8424

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

2.  Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes.

Authors:  P Joly; J M Guillon; C Mayaud; F Plata; I Theodorou; M Denis; P Debre; B Autran
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

Review 3.  Immunoregulatory T-cell pathways.

Authors:  D R Green; P M Flood; R K Gershon
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

4.  Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.

Authors:  J S Smolen; P Bettelheim; U Köller; S McDougal; W Graninger; T A Luger; W Knapp; K Lechner
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

5.  Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.

Authors:  J P Siegel; J Y Djeu; N I Stocks; H Masur; E P Gelmann; G V Quinnan
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

6.  Expression of functional alpha beta T cell receptor gene rearrangements in suppressor T cell hybridomas correlates with antigen binding, but not with suppressor cell function.

Authors:  M Collins; V K Kuchroo; M J Whitters; R M O'Hara; K Kelleher; R T Kubo; M E Dorf
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

7.  Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men.

Authors:  C J van Noesel; R A Gruters; F G Terpstra; P T Schellekens; R A van Lier; F Miedema
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

8.  Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors.

Authors:  J Laurence; L Mayer
Journal:  Science       Date:  1984-07-06       Impact factor: 47.728

9.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

Authors:  C M Walker; D J Moody; D P Stites; J A Levy
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

10.  Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus.

Authors:  N Chirmule; V S Kalyanaraman; N Oyaizu; H B Slade; S Pahwa
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

View more
  5 in total

1.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

Authors:  M Clerici; F T Hakim; D J Venzon; S Blatt; C W Hendrix; T A Wynn; G M Shearer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

2.  Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels.

Authors:  Eli Boritz; Brent E Palmer; Cara C Wilson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 3.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

4.  Relationship of HIV-1 provirus load, CD8+ CD11+ T cells and HIV-1 envelope-specific cytotoxic T lymphocytes in HIV-infected asymptomatic offients.

Authors:  S K Kundu; T C Merigan
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

5.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

Authors:  M Clerici; T A Wynn; J A Berzofsky; S P Blatt; C W Hendrix; A Sher; R L Coffman; G M Shearer
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.